Romiset 250 mcg

Romiset 250 mcg is a prescription injectable medicine containing Romiplostim 250 mcg/vial, shown as an Alkem product. It is supplied as a lyophilized powder for solution for injection and is used under medical supervision to help increase platelet counts in selected patients with immune thrombocytopenia, because apparently platelets also need motivational coaching.  Romiplostim is a thrombopoietin receptor agonist used for low platelet counts in adults and children with ITP when other treatments have not worked well enough.

Composition:

Romiplostim – 250 mcg/vial
r-DNA origin

Key Information:

Brand Name: Romiset
Strength: 250 mcg/vial
Active Ingredient: Romiplostim
Dosage Form: Lyophilized powder for solution for injection
Medicine Type: Platelet-stimulating medicine / Thrombopoietin receptor agonist
Manufacturer/Brand Shown: Alkem
Common Use: Treatment of low platelet count in immune thrombocytopenia
Administration: Injection, usually subcutaneous as directed by a healthcare professional
Category: Prescription medicine
Pack Size: Single-use vial

How It Works:

Romiset 250 mcg works by stimulating the thrombopoietin receptor, which helps the bone marrow produce more platelets. This may reduce bleeding risk in patients with immune thrombocytopenia when used exactly as prescribed. Romiplostim is generally used to maintain platelet counts at a safer level, not to make platelet counts “perfect,” because medicine is annoying like that.

Potential Indications:

• Immune thrombocytopenia, also called ITP
• Chronic or persistent low platelet count in selected patients
• Patients who have not responded well to corticosteroids, immunoglobulins, or splenectomy
• Other specialist-directed use based on platelet count and diagnosis

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
This injection should be prepared and administered only by trained medical staff.
Do not self-administer unless clearly trained and instructed by a doctor.
Romiplostim dosing is adjusted based on platelet response, and platelet counts are monitored during treatment. Official information notes close monitoring of platelet counts during ITP treatment.
Store as per the physical product label and hospital pharmacy instructions.
Keep out of reach of children.

Important Safety Information:

Romiplostim should be used carefully under specialist supervision, especially in patients with blood clot risk, liver disease, bone marrow disorders, history of cancer-related blood disorders, or abnormal blood counts.

Possible side effects may include:

• Headache
• Joint or muscle pain
• Dizziness
• Fatigue
• Nausea
• Injection-site reaction
• Increased platelet count
• Risk of blood clots
• Low platelet count after stopping treatment
• Bone marrow changes in some patients

Serious symptoms such as chest pain, shortness of breath, swelling/pain in legs, sudden weakness, severe headache, vision changes, unusual bleeding, or bruising should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, reconstitution instructions, dosage directions, and route of administration.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.